Understanding the mechanism by which MC4R agonists mediate their effects on sexual behavior is important, not only for the ongoing development of melanocortin-based therapies for psychosexual disorders but also for obesity medicine, where related MC4R agonists are rapidly being developed (22). The gene discussed is MC4R; the disease is psychosexual disorder.